Gene expression profiling in cervical cancer: State of the art and future directions

Cancer Journal

Volumn 12, Issue 3, 2006, Pages 170-174

  Klopp, Ann H ^a   Eifel, Patricia J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; OLIGONUCLEOTIDE;

CANCER RADIOTHERAPY; CANCER STAGING; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; METHODOLOGY; MICROARRAY ANALYSIS; NOTE; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CANCER;

FEMALE; FORECASTING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 33745137896     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200605000-00002     Document Type: Note

References (20)

1. Wong YF, Sahota DS, Cheung TH et al. Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J 2006;12:189-193.
2. Eifel PJ, Winter K, Morris M et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22:872-880.
3. van de Vijver MJ, He YD, van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
4. Brenton JD, Carey LA, Ahmed AA et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 2005;23:7350-7360.
5. Loi S, Buyse M, Sotiriou C et al. Challenges in breast cancer clinical trial design in the postgenomic era. Curr Opin Oncol 2004;16:536-541.
6. Ahmed AA, Brenton JD. Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt. Breast Cancer Res 2005;7:96-99.
7. Pusztai L, Hess KR. Clinical trial design for microarray predictive marker discovery and assessment. Ann Oncol 2004;15:1731-1737.
8. Bachtiary B, Schind M, Potter R et al. Overexpression of hypoxia-inducible factor 1 alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 2003;9:2234-2240.
9. Burri P, Djonov V, Aebersold DM et al. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:494-501.
10. Kim JY, Shin HJ, Kim TH et al. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer. J Cancer Res Clin Oncol 2006;1-7.
11. Harima Y, Sawada S, Miyazaki Y, Kin K et al. Expression of Ku80 in cervical cancer correlates with response to radiotherapy and survival. Am J Clin Oncol 2003;26: e80-85.
12. Wilson CR, Davidson SE, Margison GP et al. Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer 2000;83:1702-1706.
13. Santucci MA, Barbieri E, Frezza G et al. Radiation-induced gadd45 expression correlates with clinical response to radiotherapy of cervical carcinoma. Int J Radiat Oncol Biol Phys 2000;46:411-416.
14. Green MM, Hutchison GJ, Valentine HR et al. Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix. Br J Cancer 2005;92:449-458.
15. Harima Y, Harima K, Shikata N, Oka A et al. Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer. J Cancer Res Clin Oncol 1998;124:503-510.
16. Liu SS, Leung RC, Chan KY et al. p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 2004;10:3309-3316.
17. Kitahara O, Katagiri T, Tsunoda T et al. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 2002;4:295-303.
18. Chung YM, Kim BG, Park CS et al. Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 2005;117:194-201.
19. Harima Y, Togashi A, Horikoshi K et al. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 2004;60:237-248.
20. Wong YF, Selvanayagam ZE, Wei N et al. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 2003;9:5486-5492.